Cano Health Inc. (CANO) Business Metric Overview - Stocknear

Cano Health Inc.

NYSE: CANO · Real-Time Price · USD
2.30
-0.05 (-2.13%)
At close: Feb 02, 2024, 10:00 PM

Cano Health Revenue Breakdown

Period Ending Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Medicare Revenue 602.61M 615.22M 552.36M 447.25M 334.7M
Medicare Revenue Growth -2.05% +11.38% +23.50% +33.63% n/a
Other Capitated Revenue Revenue 52.88M 59.13M 95.77M 54.53M 44.51M
Other Capitated Revenue Revenue Growth -10.58% -38.26% +75.63% +22.51% n/a
Fee For Service Revenue 9.7M 9.97M 12.82M 8.18M 4.39M
Fee For Service Revenue Growth -2.70% -22.22% +56.78% +86.28% n/a
Other Revenue 11.42M 8.5M 10.47M 6.75M 1.35M
Other Revenue Growth +34.34% -18.78% +55.16% +400.82% n/a
Pharmacy Revenue 12.76M 11.52M 17.99M 10.1M 8.22M
Pharmacy Revenue Growth +10.80% -36.00% +78.22% +22.87% n/a

Operating Expense Breakdown

Period Ending Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Selling, General, and Administrative Revenue 80.82M 99.42M 96.47M 107.83M 111.77M 106.18M 96.59M 93.35M 75.93M 46.57M 35.29M 33.73M 27.39M 21.86M
Selling, General, and Administrative Revenue Growth -18.71% +3.05% -10.53% -3.52% +5.26% +9.93% +3.47% +22.94% +63.02% +31.99% +4.62% +23.14% +25.31% n/a
Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a